Tetralogy of fallot primary prevention

	Tetralogy of fallot Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Tetalogy of Fallot from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural history, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
ACC/AHA Guidelines for Evaluation and Follow-up
;
Tetralogy of fallot primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tetralogy of fallot primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tetralogy of fallot primary prevention
CDC on Tetralogy of fallot primary prevention
Tetralogy of fallot primary prevention in the news
Blogs on Tetralogy of fallot primary prevention
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Tetralogy of fallot primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

There are no established measures for the primary prevention of Tetralogy of Fallot.

Primary Prevention

There are no established measures for the primary prevention of Tetralogy of Fallot.

Prevention of Cyanosis

The following factors may reduce systemic vascular resistance (SVR) and exacerbate shunting which in turn exacerbate cyanosis and should be avoided if at all possible:^[1]

Acidosis
Bathing in hot water
Fever
Stress
Infection
Posture (upright, not squatting)
Exercise
Beta-adrenergic agonists
Dehydration
Closure of the patent ductus arteriosus

Prevention of Infective Endocarditis

Antibiotic prophylaxis should be administered.

References

↑ CRAIG JM, DARLING RC, ROTHNEY WB (1957). "Total pulmonary venous drainage into the right side of the heart; report of 17 autopsied cases not associated with other major cardiovascular anomalies". Lab. Invest. 6 (1): 44–64. PMID 13386206.

Template:WH Template:WS

[pmid13386206-1] CRAIG JM, DARLING RC, ROTHNEY WB (1957). "Total pulmonary venous drainage into the right side of the heart; report of 17 autopsied cases not associated with other major cardiovascular anomalies". Lab. Invest. 6 (1): 44–64. PMID 13386206.

[1]